Whyte M P, Schranck F W, Armamento-Villareal R
Metabolic Research Unit, Shriners Hospital for Crippled Children, St. Louis, Missouri 63131, USA.
J Clin Endocrinol Metab. 1996 Nov;81(11):4075-80. doi: 10.1210/jcem.81.11.8923863.
X-Linked hypophosphatemia (XLH) is a sex-linked dominant disorder. It is possible that females are more mildly affected than males. No information is available regarding other potential genetic influences on XLH expression in patients, such as race, anticipation, parent of origin, or molecular heterogeneity. We investigated the above potential genetic influences on XLH expressivity using data from 116 pediatric patients. To compare biochemical parameters, we used data from the 30 prepubertal children (23 girls and 7 boys) selected because they had been without medical therapy for at least 3 months (25 of 30 never treated). To compare height z-scores, we used data from the 27 patients (pre- or postpubertal) selected because they had never received medical or surgical treatment. Ascertainment bias (i.e. referral of girls who were severely affected) was not apparent (observed female/male ratio, 1.64; expected, 2.00; P = 0.29). Parameters of mineral homeostasis did not show statistically significant differences between girls vs. boys, sporadic vs. multigenerational cases (except lower fasting serum phosphate levels in sporadic cases; mean +/- SEM, 2.68 +/- 0.10 vs. 3.02 +/- 0.04 mg/dL; P = 0.049), blacks vs. whites, or for the girls for whom affected fathers vs. mothers transmitted the disorder. Height z-scores correlated with renal phosphate reclamation (i.e. tubular maximum of phosphorus/glomerular filtration rate; r = 0.68; P = 0.014), but were not different for the groupings above. Furthermore, we found no evidence for meiotic drive or for a parental age effect to explain the 18.3% of patients that were new mutations for XLH. Our data fail to show any evidence for genetic heterogeneity or for gender, race, anticipation, or parent of origin effects on XLH expression in children. Despite the recent discovery of a gene (PEX) that is mutated in XLH, the sex-linked dominant phenotype and apparent absence of a gene dose effect in XLH expression in children require explanation.
X连锁低磷血症(XLH)是一种X连锁显性疾病。女性可能比男性受影响程度较轻。关于患者中其他可能对XLH表达有影响的遗传因素,如种族、遗传早现、起源亲本或分子异质性,目前尚无相关信息。我们使用116例儿科患者的数据,研究了上述对XLH表达的潜在遗传影响。为比较生化参数,我们使用了30例青春期前儿童(23名女孩和7名男孩)的数据,这些儿童入选是因为他们至少3个月未接受药物治疗(30例中有25例从未接受过治疗)。为比较身高Z评分,我们使用了27例患者(青春期前或青春期后)的数据,这些患者入选是因为他们从未接受过药物或手术治疗。确诊偏倚(即严重受影响女孩的转诊)并不明显(观察到的女性/男性比例为1.64;预期比例为2.00;P = 0.29)。矿物质稳态参数在女孩与男孩、散发病例与多代病例之间(除散发病例空腹血清磷酸盐水平较低外;均值±标准误,2.68±0.10 vs. 3.02±0.04 mg/dL;P = 0.049)、黑人与白人之间,或对于受影响父亲与母亲传递该疾病的女孩之间,均未显示出统计学上的显著差异。身高Z评分与肾脏磷酸盐重吸收相关(即磷的肾小管最大重吸收量/肾小球滤过率;r = 0.68;P = 0.014),但在上述分组中并无差异。此外,我们没有发现减数分裂驱动或亲本年龄效应的证据来解释18.3%的XLH新突变患者。我们的数据未能显示出任何遗传异质性或性别、种族、遗传早现或起源亲本效应影响儿童XLH表达的证据。尽管最近发现了一个在XLH中发生突变的基因(PEX),但X连锁显性表型以及儿童XLH表达中明显不存在基因剂量效应仍需要解释。